Exagen

$10.09 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Exagen

Exagen Inc. is a commercial-stage life sciences company. The Company offers physicians testing for patients and healthcare providers in diagnosis, prognosis and monitoring of autoimmune conditions. Its diagnostic tests include AVISE connective tissue disease (CTD), AVISE Lupus and AVISE antiphospholipid syndrome (APS). Its prognostic tests include AVISE systemic lupus erythematosus (SLE) Prognostic, AVISE Platelet-bound C4d (PC4d) and AVISE Anti- carbamylated proteins (CarP). Its monitoring tests include AVISE SLE Monitor, AVISE methotrexate (MTX) and AVISE hydroxychloroquine (HCQ).

Stock Analysis

last close $9.73
1-mo return -19.7%
3-mo return -29.5%
avg daily vol. 37.32T
52-week high 24.67
52-week low 9.63
market cap. $178M
forward pe -
annual div. -
roe -34.4%
ltg forecast -
dividend yield -
annual rev. $48M
inst own. 77%
baraka

Subscribe now for daily local and international financial news

Subscribe